Is Novavax Still a Buy After Doubling in Two Days?

Novavax (NASDAQ: NVAX) soared more than 2,000% in 2020 as investors bet on the future of its coronavirus vaccine candidate. Then it extended gains at a reasonable pace as the new year began. But even if you’re very bullish on this biotech stock, you might not have expected what hRead MoreMarketsMarkets Feed